Citigroup Global Markets India Private Ltd has submitted to the Exchange a copy Pre-offer Advertisement in accordance with Regulation 18(7) and other applicable Provisions of the SEBI ( SAST) Regulations, 2011 and Subsequent amendments thereto, and Corrigendum to the detailed public shatement and the letter of offer for the attention of the shareholders of the company.

Open offer triggeredListed-company acquisitionStrategic Transactions View source PDF Explain this filing

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹4949.20

prior close

₹4954.80

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-2.7%+2.5% vs market

Pharmaceuticals peers, median of 148sector-3.1%+2.9% vs sector

On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 2.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.2

15m

-0.2

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2-2.7+2.5-3.1+2.9

Next day

-0.1-2.7+2.6-2.9+2.8

-0.2-2.8+2.6-3.6+3.3

-0.2-4.9+4.7-4.9+4.7

-0.2-5.0+4.8-4.8+4.7

-0.0-3.6+3.6-3.5+3.5

+0.1-5.0+5.1-5.3+5.4

15d

+0.0+4.8-4.7-0.6+0.6

+2.0+5.6-3.6+0.2+1.9

+2.2+8.3-6.0-1.6+3.9

+1.0+8.8-7.7+1.0-0.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Citigroup Global Markets India, acting as the manager to a public offer, has submitted a pre-offer advertisement and a corrigendum to the detailed public statement and letter of offer to the Exchange. The filings are made under Regulation 18(7) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which is the standard procedure before launching an open offer to buy shares from public shareholders. A corrigendum indicates corrections or updates to the earlier published offer document. Shareholders of Sanofi Consumer Healthcare India are being addressed directly through this submission.

Likely market impact

Shareholders should review the corrigendum carefully as it may contain revised offer price, revised dates, or corrected terms of the open offer. The submission of the pre-offer advertisement signals that the open offer process is actively progressing and shareholders may need to evaluate their participation before the offer window opens.